流行病引发的紧急供应链管理创新:基于图书识别和动态主题模型的科学度分析
Tian Xie1,2, Gui-Ye Dai1, Wei-Fan Chen2
1School of Economics, Management and Law, University of South China, Hunan, PR China.
Disaster medicine and public health preparedness
|April 11, 2025
概括
像COVID-19这样的大流行病会影响供应链. 本研究分析了流行病引发的紧急供应链创新,确定了行业,管理和技术的关键研究趋势.
科学领域:
- 供应链管理 供应链管理
- 流行病学 流行病学
- 知识管理知识管理
背景情况:
- 包括COVID-19在内的重大流行病严重破坏了全球供应链.
- 在流行病期间,需要有弹性和适应性的紧急供应链至关重要.
- 现有关于流行病特定供应链管理的研究需要进行系统分析.
研究的目的:
- 在流行病期间系统分析紧急供应链中的知识创新.
- 确定当前的研究格局和流行病引发的供应链创新的新趋势.
- 使用文献计量和主题建模技术,提供对该领域的定量概述.
主要方法:
- 使用科学网络 (WOS) 核心集合进行系统的文献审查.
- 图书统计分析,绘制知识库和研究分布图.
- 动态主题模型 (DTM) 和回归分析以确定研究热点并预测未来的趋势.
主要成果:
- 总共有888篇出版物被确定,显示了最近研究活动的激增.
- 流行病引发紧急供应链 (PTESC) 的领域正在出现,已确定知识库和研究热点.
- 未来的研究趋势集中在关键行业的创新,管理策略和PTESC中的技术进步.
结论:
- COVID-19在紧急供应链研究中加速了学术合作和知识生成.
- 这项研究提供了对该领域的全面视角,帮助研究人员了解其范围.
- 确定了未来的研究方向,重点是加强全球卫生危机期间的供应链弹性和创新.
相关概念视频
Issues And Trends In Healthcare Delivery System
6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
Pharmacodynamic Models: Overview
163
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
163
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Steps in Outbreak Investigation
780
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
780
Infectious Diseases and Their Occurrence
100
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
100
Investigation of Disease Outbreaks
79
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
79


